Intuitive Surgical, Inc. $ISRG Shares Acquired by Vermillion Wealth Management Inc.

Vermillion Wealth Management Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 232.6% in the 2nd quarter, Holdings Channel.com reports. The firm owned 143 shares of the medical equipment provider’s stock after purchasing an additional 100 shares during the period. Vermillion Wealth Management Inc.’s holdings in Intuitive Surgical were worth $78,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Brighton Jones LLC lifted its holdings in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the last quarter. AdvisorNet Financial Inc raised its position in shares of Intuitive Surgical by 66.0% during the 1st quarter. AdvisorNet Financial Inc now owns 1,283 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 510 shares in the last quarter. Rothschild Investment LLC lifted its stake in Intuitive Surgical by 16.6% during the first quarter. Rothschild Investment LLC now owns 561 shares of the medical equipment provider’s stock worth $278,000 after purchasing an additional 80 shares during the last quarter. Beese Fulmer Investment Management Inc. boosted its holdings in Intuitive Surgical by 9.5% in the first quarter. Beese Fulmer Investment Management Inc. now owns 1,750 shares of the medical equipment provider’s stock valued at $867,000 after purchasing an additional 152 shares in the last quarter. Finally, Fifth Third Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 14.3% in the first quarter. Fifth Third Wealth Advisors LLC now owns 10,563 shares of the medical equipment provider’s stock valued at $5,232,000 after purchasing an additional 1,318 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $441.12 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a 50-day simple moving average of $469.43 and a 200-day simple moving average of $501.66. The company has a market capitalization of $158.13 billion, a price-to-earnings ratio of 61.52, a price-to-earnings-growth ratio of 4.62 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the prior year, the business earned $1.78 EPS. The firm’s revenue was up 21.4% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on ISRG shares. Piper Sandler restated an “overweight” rating and set a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. UBS Group boosted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research report on Wednesday, July 23rd. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Truist Financial lifted their target price on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Finally, Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Friday. Thirteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $595.95.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 over the last three months. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.